Home » Topics » Regulatory

Regulatory
RSS

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

FDA approves Ajovy for preventive treatment of migraine

Sep. 17, 2018

FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia

Sep. 14, 2018

Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe

Sep. 14, 2018

Elunate approved in China for colorectal cancer

Sep. 5, 2018

European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura

Sep. 3, 2018

FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1

Aug. 31, 2018

European Commission approves Onpattro for hATTR with polyneuropathy

Aug. 31, 2018

FDA approves Jivi for hemophilia A

Aug. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...